Comparative analysis of Endoxifen, Tamoxifen and Fulvestrant: A Bioinformatics Approach to Uncover Mechanisms of Action in Breast Cancer.

The article discusses a comparative analysis of the drugs Endoxifen, Tamoxifen, and Fulvestrant in the context of breast cancer treatment. Through bioinformatics approaches, the study explores the mechanisms of action of these drugs, highlighting their effects on estrogen signaling, cell cycle pathways, apoptosis, and immune responses. The research suggests that advanced AI-driven methodologies can enhance the understanding of endocrine therapy mechanisms in breast cancer, potentially aiding in the selection of more effective therapies and the identification of drug-specific biomarkers. [Extracted from the article]